Vessel Sealing Devices Global Market Insights to 2025

Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme

Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

October 21, 2020

The vessel sealing devices market studied was projected to grow with a CAGR of nearly 5.6% over the forecast period. The major factors attributing to the growth of the market are the increasing number of invasive surgical processes and technological advancement in medical devices.

Furthermore, the growing demand for reliable and efficient technologies during surgeries to decrease blood loss and infection rates and reduce operative time is the major reason for the market growth. Rising investments in the surgical instruments by the hospitals and government initiatives are boosting the market. However, the high cost of the instruments involved and the complications arising after using the devices are the major drawbacks of the market growth.

Key Market Trends

The laparoscopic segment accounted for major share of the market in the forecast period.

  • Laparoscopy, is a surgical diagnostic method used to analyze the organs inside the abdomen. It’s a minimally invasive procedure that requires only small incisions. Laparoscopy uses an instrument called a laparoscope to look at the abdominal organs. Vessel sealing devices are the major part of the laparoscopic surgeries that are performed.
  • The major factors driving the growth of the segment are the increasing awareness of the advantages of laparoscopic surgeries over the open surgeries and an increasing number of laparoscopic surgeries worldwide.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall vessel sealing devices market, throughout the forecast period. The largest share is mainly due to presence of key players and increase in per capita healthcare spending and expansion in the investment made by the major market players in the region. Furthermore, growing awareness among the population to the advantages of the surgeries with such advanced technology. High adoption of surgical procedures with advanced energy in the United States, increase in the number of approvals for new devices by the FDA, and rise in the fraction of minimally invasive surgical procedures performed in the United States subsidize to North America’s high market share in the market.

Competitive Landscape

The vessel sealing devices market is moderately competitive and consists of several major players. Some of the market players are Medtronic, B. Braun Melsungen AG, Erbe Medical India Pvt Ltd, Olympus Corporation, Ethicon US, LLC (Johnson and Johnson), Boston Scientific Corporation, Symmetry Surgical, Inc., CONMED Corporation, and Bolder Surgical Holdings, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Number of Surgical Procedures

4.2.2 Technological Advancements in Vessel Sealing Devices

4.3 Market Restraints

4.3.1 Complications of the Vessel Sealing Devices

4.3.2 High Cost of Surgeries

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 By Product

5.1.1 Generators

5.1.2 Instruments

5.1.3 Accessories

5.2 By Application

5.2.1 General Surgery

5.2.2 Laparoscopic Surgery

5.3 By End User

5.3.1 Hospitals

5.3.2 Ambulatory Surgical Centers

5.3.3 Other End Users

5.4 By Geography

5.4.1 North America United States Canada Mexico

5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe

5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa

5.4.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles

6.1.1 Medtronic PLC

6.1.2 B Braun Melsungen AG

6.1.3 Erbe Medical India Pvt. Ltd

6.1.4 Olympus Corporation

6.1.5 Ethicon US LLC (Johnson & Johnson)

6.1.6 Boston Scientific Corporation

6.1.7 Symmetry Surgical Inc.

6.1.8 OmniGuide Holdings Inc.

6.1.9 CONMED Corporation

6.1.10 Bolder Surgical Holdings Inc.


More on this here.



Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin

Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment.

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

Subscribe to Medical Device News Magazine here.

Related Articles